RF
GILD icon

Rossby Financial’s Gilead Sciences GILD Stock Holding History

Rossby Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225K Buy
1,601
+675
+73% +$94.5K 0.05% 354
2025
Q4 		$114K Buy
926
+101
+12% +$12.3K 0.04% 382
2025
Q3 		$91.7K Buy
825
+7
+0.9% +$796 0.03% 413
2025
Q2 		$90.7K Buy
818
+146
+22% +$15.5K 0.03% 383
2025
Q1 		$69.3K Sell
672
-1,839
-73% -$190K 0.03% 409
2024
Q4 		$232K Buy
+2,511
New +$226K 0.14% 162

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Rossby Financial's GILD Position: Q1 2026 in Review

Rossby Financial increased its Gilead Sciences (GILD) stake by 73% in Q1 2026, buying an estimated $94.5K and bringing the position to 1,601 shares worth $225K. The position accounts for 0.05% of the portfolio, ranked #354.

Rossby Financial first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $232K in Q4 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Rossby Financial held 1,601 shares of Gilead Sciences worth $225K as of Q1 2026.
  • Rossby Financial bought 675 Gilead Sciences shares in Q1 2026, an estimated $94.5K.
  • Gilead Sciences made up 0.05% of Rossby Financial's portfolio in Q1 2026, its #354 holding.
  • Rossby Financial first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • Rossby Financial's Gilead Sciences position peaked at $232K in Q4 2024.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Rossby Financial's 13F filing for Q1 2026, filed 11 May 2026.